KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) Operating Margin (2016 - 2025)

Historic Operating Margin for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to 30.34%.

  • Gsk's Operating Margin rose 279800.0% to 30.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.41%, marking a year-over-year increase of 53900.0%. This contributed to the annual value of 12.82% for FY2024, which is 94200.0% down from last year.
  • According to the latest figures from Q3 2025, Gsk's Operating Margin is 30.34%, which was up 279800.0% from 25.33% recorded in Q2 2025.
  • Gsk's 5-year Operating Margin high stood at 31.89% for Q1 2022, and its period low was 1.99% during Q4 2021.
  • Over the past 5 years, Gsk's median Operating Margin value was 23.47% (recorded in 2021), while the average stood at 21.97%.
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by -870700bps in 2021, then skyrocketed by 279800bps in 2025.
  • Over the past 5 years, Gsk's Operating Margin (Quarter) stood at 1.99% in 2021, then soared by 1100bps to 23.9% in 2022, then rose by 25bps to 29.89% in 2023, then tumbled by -31bps to 20.57% in 2024, then surged by 48bps to 30.34% in 2025.
  • Its Operating Margin was 30.34% in Q3 2025, compared to 25.33% in Q2 2025 and 29.48% in Q1 2025.